+Compare
MASS
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
227.63M

MASS 908 Devices Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for MASS with price predictions
07:00 PM EST Nov 26, 2023

MASS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for MASS turned positive on November 14, 2023. Looking at past instances where MASS's MACD turned positive, the stock continued to rise in of 26 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MASS's RSI Oscillator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 17, 2023. You may want to consider a long position or call options on MASS as a result. In of 55 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MASS moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MASS crossed bullishly above the 50-day moving average on November 20, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MASS advanced for three days, in of 176 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MASS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MASS broke above its upper Bollinger Band on November 03, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MASS entered a downward trend on November 02, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.248) is normal, around the industry mean (25.079). P/E Ratio (0.000) is within average values for comparable stocks, (79.545). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.242). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (4.417) is also within normal values, averaging (45.510).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MASS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MASS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 702%. BOEUF experienced the highest price growth at 168%, while LNDZF experienced the biggest fall at -74%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

MASS is expected to report earnings to rise 20.59% to -26 cents per share on March 05

908 Devices MASS Stock Earnings Reports
Q4'23
Est.
$-0.27
Q3'23
Beat
by $0.08
Q2'23
Beat
by $0.04
Q1'23
Missed
by $0.05
Q4'22
Missed
by $0.06
The last earnings report on November 07 showed earnings per share of -21 cents, beating the estimate of -30 cents. With 70.93K shares outstanding, the current market capitalization sits at 227.63M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 254-1500
Employees
227
Web
https://www.908devices.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREOX14.850.22
+1.50%
Perritt Ultra MicroCap
FASIX12.930.04
+0.31%
Fidelity Asset Manager® 20%
WAIGX22.580.04
+0.18%
Wasatch International Growth Investor
NRAAX41.87-0.01
-0.02%
Neuberger Berman Sustainable Equity A
EUGAX20.35-0.01
-0.05%
Morgan Stanley Europe Opportunity A

MASS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASS has been loosely correlated with ME. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MASS jumps, then ME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASS
1D Price
Change %
MASS100%
-2.56%
ME - MASS
50%
Loosely correlated
-2.24%
TWST - MASS
49%
Loosely correlated
-1.69%
RVTY - MASS
49%
Loosely correlated
-2.04%
NVTA - MASS
48%
Loosely correlated
-1.18%
QTRX - MASS
45%
Loosely correlated
-1.92%
More

Groups containing MASS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASS
1D Price
Change %
MASS100%
-2.56%
Medical Specialties
(undefined stocks)
46%
Loosely correlated
-0.03%
Medical Specialties
(undefined stocks)
46%
Loosely correlated
-0.03%